✦ LIBER ✦

Oral absorption of cimetidine and its clearance in patients with renal failure

✍ Scribed by R. Larsson; G. Bodemar; B. Norlander

Publisher: Springer
Year: 1979
Tongue: English
Weight: 499 KB
Volume: 15
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00563098

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of oral diltiazem and f

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)

Hemofiltration clearance of flecainide i

Hemofiltration clearance of flecainide in a patient with acute renal failure

✍ A. Borgeat; J. Biollaz; B. Freymond; M. Bayer-Berger; R. Chiolero 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 132 KB

Antisecretory effect and oral pharmacoki

Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure

✍ C. W. Howden; C. D. Payton; P. A. Meredith; D. M. A. Hughes; A. I. Macdougall; J 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 435 KB

GD-DOTA: Evaluation of its renal toleran

GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure

✍ Marie-France Bellin; Gilbert Deray; Ubald Assogba; Eric Auberton; Farez Ghany; E 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Gd-DOTA is an intravenous contrast medium used in MRI. The clinical and biological tolerance of Gd-DOTA was studied in patients with chronic renal failure (e.g., those having a glomerular filtration rate of less than 60 mL/min). Twenty patients were randomized into two groups. In the control group,

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of oral nitrendipine solution in hypertensive patients with advanced renal failure

✍ H. Kierdorf; A. Müller; P. M. Blanke; J. Gellert; B. Heintz; K. D. Rämsch; M. Wa 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 656 KB

Nitrendipine solution 5 mg.ml-1 in the dose of 5 mg was given orally to 20 patients with chronic renal failure and elevated diastolic blood pressure (> or = 110 mmHg), of whom 10 were on maintenance haemodialysis (endogenous creatinine clearance < 5 ml.min-1) and 10 were at the predialysis stage (en

Oral pharmacokinetics of pirenzepine in

Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis

✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1